Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Unanswered IR questions redux......

Dear PTSC IR,

Based on this response, what you are saying is the Baroni report, directly or indirectly had nothing to do with the personnel changes in October? The Baroni report had to have been completed based on the wording in the restructuring PR, "The changes being made are intended to accelerate the transformation of the PDSG acquisition and enable a faster implementation of its strategic direction (while the merger misrepresentation was buried in the 10-Q)." Even the "Major Reorganization" headline of the PR basically says the company has taken a major change of direction, which my original inquiry (question #1 made back in October) was about. If replacing three key members of your business does not constitute a major change of direction, you've stumped me as to what does.

Dear Mr. xxxxxxx,

The Company has carefully provided information regarding the activities of the Eclat consulting team in a manner that is fair to all investors. And management will continue to provide information in the form of press releases and filings with the SEC. But, we cannot provide information connected with activities of the Company to individual shareholders or groups of shareholders due to Federal securities laws. Information regarding these matters will be made available to all shareholders at the same time.

Share
New Message
Please login to post a reply